Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Integrative tissue analysis of men with prostate cancer

ABSTRACT: Prostate cancer is a multi-focal disease and understanding the relationship between primary disease and relapse has remained a challenge.

ORGANISM(S): Homo sapiens

PROVIDER: GSE129960 | GEO | 2020/06/30

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Integrative tissue analysis of men with prostate cancer II

Project description:Prostate cancer is a multi-focal disease and understanding the relationship between primary disease and relapse has remained a challenge.

2020-06-30 | GSE130046 | GEO

Integrative tissue analysis of men with prostate cancer V

Project description:Prostate cancer is readily curable if detected early. The overall goal of this study is to conduct integrative profiling of tumor and blood genomics and transcriptomics.

2021-09-30 | GSE183019 | GEO

Integrative tissue analysis of men with prostate cancer III

Project description:Prostate cancer is readily curable if detected early. The overall goal of this study is to conduct integrative profiling of tumor and blood genomics and transcriptomics.

2021-09-30 | GSE162868 | GEO

Integrative tissue analysis of men with prostate cancer IV

Project description:Prostate cancer is readily curable if detected early. The overall goal of this study is to conduct integrative profiling of tumor and blood genomics and transcriptomics.

2021-09-30 | GSE183015 | GEO

Integrative tissue analysis of men with prostate cancer VI

Project description:Prostate cancer is readily curable if detected early. The overall goal of this study is to conduct integrative profiling of tumor and blood genomics and transcriptomics.

2022-04-27 | GSE201284 | GEO

Integrative tissue analysis of men with prostate cancer

Project description:Integrative tissue analysis of men with prostate cancer

| PRJNA533294 | ENA

Integrative tissue analysis of men with prostate cancer

Project description:Integrative tissue analysis of men with prostate cancer

| PRJNA540338 | ENA

Integrative tissue analysis of men with prostate cancer

Project description:Integrative tissue analysis of men with prostate cancer

| PRJNA540339 | ENA

Integrative tissue analyses of men with prostate cancer

Project description:Integrative tissue analyses of men with prostate cancer

| PRJNA758910 | ENA

Integrative miRNA networks predict prostate cancer recurrence

Project description:Developing an effective predictor of tumour recurrence is an important challenge in the management of localized prostate cancer. Accurate prediction of disease-free survival is essential for decision-making before or after definitive local therapy, and would allow identification of patients who may derive benefit from adjuvant therapy. Today these decisions are largely based on the clinic-pathologic prognostic factors of tumour size, extent and grade along with serum PSA abundance. MicroRNAs (miRNAs) are promising class of biomarkers to improve patient risk-stratification: they show differential abundance across prostate cancer sub-types and have both oncogenic and tumour-suppressive roles. Here, we report the miRNA abundance profiling of 319 prostate tumours with matching detailed clinical annotation, long-term follow-up and accompanying genetic and epigenetic data including mRNA abundance, copy number alterations, point mutations and methylation. We built a cancer driver-miRNA-target regulatory network to characterize the extent to which genomic, transcriptional and post-transcriptional events contribute to the miRNA abundance architecture. By linking this network with machine-learning we created a multi-modal biomarker that accurately predicts biochemical recurrence after definitive local therapy. We find that combining miRNA information with genetic and epigenetic drivers and clinicopathological parameters improves biomarker accuracy, and quantifies the value of multi-modal biomarkers that exploit the regulatory architecture of gene expression in their development.

2024-04-05 | GSE135535 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data